All Infection Prevention & Control articles – Page 5
-
News
New mega RNA virus may hold the key to mass oyster die-offs
Scientists have discovered a previously unknown virus in farmed Pacific oysters during a mass die-off in B.C., Canada. The discovery serves as a reminder that growers should exercise caution when moving young oysters, to prevent potential spread of pathogens.
-
News
Smart wound monitor poised to improve chronic infection care
Researchers have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.
-
News
Scientists discover how leukemia virus stays hidden in the body
A research team has discovered how the human T-cell leukemia virus type 1 (HTLV-1) silently persists in the body. Their findings identify a previously unknown genetic “silencer” element that keeps the virus in a dormant, undetectable state.
-
News
Statistical modeling can help tackle neglected tropical diseases among migrant populations
A study of migrants in Italy has shown how statistical modelling can help improve the identification of Neglected Tropical Disease (NTD) infections.
-
News
Skin test reagent proves effective and safe for TB diagnosis in children
A new class of skin test reagents based on Mycobacterium tuberculosis (MTB)-specific antigens has been developed. A phase III clinical trial suggests that C-TST is an effective and safe option for diagnosing pediatric TBI.
-
News
Researchers develop bacterial cellulose-based dressing for advanced burn wound care
Scientists have developed an innovative bacterial cellulose (BC)-based hemostatic dressing that enables rapid and sustained bleeding control.
-
News
Scientists pinpoint optimal dose of methylprednisolone for treating severe Mycoplasma pneumoniae pneumonia
Investigators have compared the efficacy of low- versus high-dose of methylprednisolone in preventing pulmonary lesions in children with severe Mycoplasma pneumoniae pneumonia.
-
News
New farmer-led research project explores how badger vaccination may be used within TB eradication strategy
A progressive new UK project is underway to explore the contribution, effectiveness and practicality of professionally scaled-up, industry delivered badger vaccination as part of a comprehensive TB eradication strategy.
-
News
Immunoglobulin replacement therapy shows no reduction in serious infections for patients with CLL
In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, according to a study published in Blood Advances.
-
News
Large study uncovers specific impacts of flooding on older adult health
New research examining 17 years of data from Medicare hospitalization claims and major flooding events finds increased rates of skin diseases, nervous system diseases, and injuries or poisonings among adults aged 65 and older following major floods.
-
News
Gene therapy may block HIV transmission during breastfeeding, study shows
Delivering broadly neutralizing antibodies against HIV-1 to newborns via gene therapy provided them with multi-year protection from HIV/AIDS infection, according to an animal study.
-
News
Study highlights the severity of acute necrotizing encephalopathy in kids with the flu
For a small subset of children, influenza can trigger a rare but serious complication called influenza-associated acute necrotizing encephalopathy (ANE). Now, findings of a multicenter study suggest that ANE is often fatal in these children — despite intensive treatment.
-
News
Clinical trial finds safe, effective treatment for children with severe post-Covid syndrome
Researchers have discovered that a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID. A small, randomized clinical trialfound the oral drug larazotide was both safe and effective in treating children with MIS-C.
-
News
Economic evaluation of wastewater surveillance for COVID-19 testing in long-term care settings
The COVID-19 pandemic has placed enormous pressure on healthcare systems and economies around the world, with particularly severe impacts on vulnerable groups like residents of long-term care facilities (LTCFs). One key lesson from the pandemic is that early detection and treatment can lower hospitalization and death rates while also cutting ...
-
News
Hospital superbugs that cause sepsis and meningitis could be hitching a ride on mobile phones
Hospital superbugs that cause sepsis and meningitis could be hitching a ride on mobile phones, allowing them to escape out of healthcare settings and into the community, according to research presented at MLS Future Forum earlier this year.
-
News
‘One and done’: A single shot at birth may shield children from HIV for years, study finds
A new study shows that delivering a single injection of gene therapy at birth may offer years-long protection against HIV, tapping into a critical window in early life that could reshape the fight against pediatric infections in high-risk regions.
-
News
Experiment on joint NASA and SpaceX mission will study the effect of space travel on disease-causing bacteria
ARC/Sheba Medical Center is launching an Israeli experiment on the International Space Station to investigate how microgravity and space conditions influence bacterial virulence and antibiotic resistance.
-
News
How the common fungus Candida albicans colonizes the gut
Researchers have discovered unexpected factors that help the fungus Candida albicans settle and persist in the gut. The findings expand our knowledge of the fungus-gut interactions and offer potential solutions to reduce colonization.
-
News
Risk of deadly diarrheal diseases in children set to worsen as climate changes
Diarrhoea remains one of the most serious health threats to young children in the Global South, and new research shows that climate change is set to worsen the risk substantially.
-
News
Antiviral treatment fails to slow early-stage Alzheimer’s
A clinical trial has found that a common antiviral for herpes simplex infections, valacyclovir, does not change the course of the disease for patients in the early stages of Alzheimer’s.